Data

27 Ottobre 2020

Location

Copenhagen

Lingua

English

Nordic ePharma Day

Iscriviti
Nordic ePharma Day

As a direct result of the outbreak of the Coronavirus disease (COVID-19) and due to circumstances beyond our control, LS Academy has decided to postpone the Nordic ePharma Day 2020 in Copenhagen to 27 October 2020.


Live Evidence of the Ongoing Systemic Transformation in Clinical Trials


We live in extraordinary times for Clinical Trials conduction and Products Development.

Evolutions in technology, regulations and processes bring along challenges and opportunities for all the parties involved: patients and caregivers, health centres and institutions, healthcare professionals, regulators, sponsors, vendors and contract research organizations (CROs).

As we progressively shift away from treatment towards prevention, from sickness towards wellness, the tech industry is gaining ground, getting closer to patients (and patient’s data). How should pharma react? Competing or joining up?

While the shorter-term benefits of digitalisation are gradually becoming tangible, the long-term ambitions look into transforming the entire clinical trials operating model.

During the 6th Nordic ePharma Day conference 2020, we will focus our attention on the following topics:

  • How the Digital Transformation in the Nordic countries will ensure a better patient recruitment?
  • What solutions and strategies are now in place to implement new tools and speed up the processes avoiding delays in research?
  • How pharma manages oversight (Key Opinion Leaders, CRO selection and contracting, special study designs)?  
  • Patient involvement: ethical hurdles, practical examples, patient recruitment, study results interpretation/discussion, authorship. Have Patients accessible information on ongoing clinical trials in an easy-to-understand language?
  • How to approach the Digital Transformation: Personalised medicine, E-health, digital biomarkers?  
  • How to manage the new inspection mood? Update on typical IT focus areas and deviations seen during Good Clinical Practice inspections considering the impact of digitalization, artificial intelligence and General Data Protection Regulation 
  • What is the value of Real-World-Data (RWD) and Real-World Evidence (RWE), and why are they needed? What is the approach in Pragmatic Trials? 
  • What are ePatient Reported Outcomes (PRO) solutions/requirements? Clinical Development collaboration with patients especially regarding PROs (Quality of Life, RWE, Pharmacovigilance, Adverse Events)  

The event is designed for professionals involved in clinical trials design, conduction and management, pharmacovigilance, quality, clinical development and management of pharmaceutical products. 

This event will be a key opportunity to network and learn from knowledgeable speakers and experts in the field – experts in these hot topics from the Nordic area perspective. 

We hope you find these topics as interesting and enticing as we do. The future is here. We need to appropriately shape it in order to provide enhanced solutions for patients’ better health and quality of life. 


Scientific Board

Simona Sgarbi, Senior Real World Evidence Lead at Lundbeck
Rasmus Hogreffe, Head of Virtual Clinical Trials at LEO Innovation Lab


Who should attend?

Representatives of Pharmaceutical and Biotechnology companies, Clinical Research Organizations, Academic centers, Hospital Centers, and Clinical Technology companies. Especially Clinical Research Professionals, belonging to the following departments:  Clinical Research and Development, Quality Assurance, Regulatory, Pharmacovigilance, Clinical Operations, Statistics and Data Management, Information Technology, Market Access


For sponsorship opportunities, please contact events@lsacademy.com

Attestato di partecipazione

Scarica il programma
Attestato di partecipazione

27 Ottobre 2020

Abstract available soon

Jens Torup Østby Jens Torup Østby – Director, Health Economics & Outcomes Research at Pfizer

85% of clinical trials fail to retain enough patients, with the average dropout rate across all clinical trials at around 30% - primarily due to patient access and convenience.

In this session, Dr. Michelle Longmire will present two recent case studies highlighting how decentralized trials throughout the trial process can positively impact trial success and data quality.


Michelle Longmire Michelle Longmire – CEO at Medable

Advanced MRI and PET imaging protocols can be used in MAD and phase 2 studies to get early signals, with high precision, of structural and functional efficacy on an organ level. PET imaging can also be used to increase understanding of receptor location and occupancy. Antaros Medical have a number of examples of how these techniques have guided continued drug development. Currently we are working with 6 of the 15 biggest pharma companies in the world.

Robert Corbé Robert Corbé – Director Clinical Trial Management at Antaros Medical

The eClinical system has been fairly well developed in Norway over the last years, but still there is a long way to go.

A public platform is available, managed and developed by the  Norwegian Health Society.

From a patient perspective, one have to admit it is working fairly well to have all information readily available, easy to achieve, on one single platform, but whether its fully updated or not is another question. When most of the health care personnel doing their best to make it work, it is sad to experience that there are doctors, clinics and others in the health care system, not updating nor using the database to the extent they should, consequently it is not as good as it should be.

In this session a Patient perspective is probably worthwhile listening to?

Roald  Nystad Roald Nystad – Patient Association Expert Norway

More and more studies are replacing paper with electronic capture of patient reported outcomes (ePROs). When evaluating ePRO solutions, it is critical to consider not only fit with your protocol, but also level of control you can have over implementing the solution and integrating the ePRO results with other clinical data captured at sites in your EDC solution. This presentation will provide practical advice for adopting and engaging patients with an ePRO solution. Topics covered will range from considerations for evaluating and implementing an ePRO solution for onsite or remote data collection to working with validated instrument providers to using the results as part study submission.

Christine  Jones Christine Jones – Product Analyst at Medrio

The session will cover how we are getting ready for the Clinical Trials Regulation in DK and EU, but also how we are preparing for new kind of trials e.g. complex trial designs and decentralised clinical trials.

Lene Grejs Petersen Lene Grejs Petersen – Senior Adviser at the Danish Medicines Agency, Clinical Trial Unit

The presentation will focus on the specific challenges in relation to use of Artificial Intelligence for processing of personal data in clinical trials in the Nordic Countries (with special focus on Denmark) and how to comply with the requirements in the General Data Protection Regulation (GDPR) and associated national legislation in this context. The design of the training environment and the use of the algorithm behind the AI afterward are essential for a compliant solution which at the same time deduces the risk for non-compliance with the GDPR (including potential high fines and bad publicity).

Charlotte Bagger Tranberg Charlotte Bagger Tranberg – Managing Associate at Bech-Bruun

Research sites continually strive to improve patient recruitment and engagement practices for clinical trials in an effort to provide sponsors with the critical data they need to bring new medications to market safely. In addition, it is an ongoing challenge to retain the number of patients needed to successfully complete and validate the integrity of the study. While the industry continues to search for new solutions that simplify the process and reduce the burden on patients, there is a gap between available solutions and the adoption of those solutions by sites. The prevalent questions are: how long it will take for the majority of sites to adopt new solutions, and what is holding them back? 

In an effort to better understand the obstacles to industry-wide adoption, practical examples will be presented to discover the most prominent challenges in conducting trials, site awareness of decentralized clinical trials (DCTs), the alignment between the two preceding points, and the level of education available on telemedicine solutions.


Emil Hoeck Emil Hoeck – Director at VirTrial

The emergence of advanced technology in the life science industry are promising significant gains in trial efficiencies, collaboration and quality. However, the questions of when and how to integrate new technology must be answered by each organization before the first steps can be taken. This presentation will provide an overview of strategic considerations relevant for organizations embarking on the digital transformation journey. It will include concreate examples of use of digital technologies in Clinical and discuss the benefits and potential challenges to be expected as the industry moves toward transformational digitalization.

Franciska Darmer Franciska Darmer – Director, Clinical Advisory at NNIT

Coordinatori Scientifici

Rasmus Hogreffe
Rasmus Hogreffe Head of Virtual Clinical Trials at LEO Innovation Lab
Simona Sgarbi
Simona Sgarbi Senior Real World Evidence Lead at Lundbeck

Relatori

Charlotte Bagger Tranberg
Charlotte Bagger Tranberg Managing Associate at Bech-Bruun
Robert Corbé
Robert Corbé Director Clinical Trial Management at Antaros Medical
Franciska Darmer
Franciska Darmer Director, Clinical Advisory at NNIT
Lene Grejs Petersen
Lene Grejs Petersen Senior Adviser at the Danish Medicines Agency, Clinical Trial Unit
Emil Hoeck
Emil Hoeck Director at VirTrial
Christine  Jones
Christine Jones Product Analyst at Medrio
Michelle Longmire
Michelle Longmire CEO at Medable
Roald  Nystad
Roald Nystad Patient Association Expert Norway
Jens Torup Østby
Jens Torup Østby Director, Health Economics & Outcomes Research at Pfizer

Coordinatori Scientifici

Rasmus Hogreffe
Rasmus Hogreffe Head of Virtual Clinical Trials at LEO Innovation Lab
Simona Sgarbi
Simona Sgarbi Senior Real World Evidence Lead at Lundbeck

Sede della Conferenza

Park Inn by Radisson Copenhagen Airport Hotel
Engvej 171 - Copenhagen, Denmark

The Park Inn by Radisson Copenhagen Airport Hotel is just 5 minutes from Kastrup Airport and less than 15 minutes from the city center. With excellent public transport options, this hotel gives you easy access to the airport and the city, whether you are visiting for leisure or business. It is convenient to the city center and its attractions, including Amalienborg Palace, Nyhavn, Tivoli Gardens, the Round Tower (Rundetårn) and Rosenborg Castle. 

  Femøren (two stops to airport and six to city centre) - beside hotel

  Spittelmarkt (270 mt.)

  Copenhagen International Airport: 3 km (5 min by metro)

  Copenhagen Central Station: 7 km (10 - 15 min by car)

  In addition to the hotel venue here is some recommended hotels for accommodation in the nearby:
           - Ocean Hotel & Konference (at 1,6 km)
           - Hilton Copenhagen Airport (at 2,5 km)
           - Hotel Amager (at 3,9 km)

  Free parking around the hotel

Informazioni utili

Upon Arrival
At your arrival you will find our Staff at the Welcome Desk to greet and make you feel welcome and as comfortable as possible, providing direction and all information about the meeting, seating, refreshments.

Refreshments
Coffee breaks and networking lunch will provide a pleasant moment of refreshment and an opportunity for you to network with your industry peers. Special care about the food quality, in particular to your dietary needs or preferences, from menus of local products and flavors to vegetarian dishes.



Conference Room
All our conference facilities are safe, healthy, comfortable, aesthetically-pleasing, and accessible. They are able to accommodate the specific space and equipment needs of the conference. Equipped for audio/visual, Free Wi-Fi to allow everyone to connect with just one click.



Informative literature
All the necessary information for the Conference is provided. The environment is important to us and that's why we try to make this meeting an experience of environmental sustainability.

Fee includes
Seat at the conference, copy of presentations of Speakers who allow the distribution, informative literature for the day, networking lunch, coffee break, organisational office assistance, certificate of attendance. 

Numeri utili

Francesca Archetti
Francesca Archetti Operations & Training Manager
Annalisa De Biasi
Annalisa De Biasi Project & Scientific Manager
Enrico Pedroni
Enrico Pedroni Managing Director

Eventi passati

Prezzo della conferenza

805.00 €

Early Bird

sabato 26 settembre 2020

685.00 €

Pagamenti accettati

  • Bonifico bancario
  • Carta di credito
  • PayPal

Per informazioni:

Contatti:

Francesca Archetti
Francesca Archetti Operations & Training Manager
Annalisa De Biasi
Annalisa De Biasi Project & Scientific Manager
Enrico Pedroni
Enrico Pedroni Managing Director
Organizzata da

Formazione tecnico scientifica
in ambito farmaceutico
Via Roma 20 – 24022 – Alzano Lombardo (BG)
Tel: +39 035 515684

I Feedbacks dei partecipanti

Many rilevant discussions

Positive aspect: interactive meeting in one day event

High quality of speakers

Sharing info into different companies/organizations

Interaction with different player involved in clinical trials

Interesting topics in agenda, informal and relaxed environment

I numeri di LS Academy

2000
Anno di fondazione
1
Corsi organizzati
1
Conferenze organizzate
1
Professionisti formati

Tariffa Gruppi

Contattaci per partecipazioni multiple e beneficiare del migliore sconto

Pagamento sicuro con

Servizio clienti

Lunedì - Venerdì: 9:00 | 13:00 e 14:00 | 18:00
+39.035.515684 - info@lsacademy.com

Chiudi il menu
×
×

Carrello

Nordic ePharma Day

information request

Nordic ePharma Day

richiesta informazioni

Nordic ePharma Day

richiesta di sponsorizzazione

Termini e Condizioni

Corsi
la quota comprende: Ingresso al corso, documentazione didattica, pranzi e coffee break, assistenza segreteria organizzativa, attestato di partecipazione.
Lo sconto early bird non si applica alla quota per Freelance – Accademia – Pubblica Amministrazione.
Il corso si svolgerà al raggiungimento di un minimo di 8 partecipanti. In caso contrario verrà data comunicazione agli iscritti almeno una settimana prima dalla data del corso.
Per maggiori informazioni riguardanti l’iscrizione all’evento, potete contattare la segreteria organizzativa:
training@LSAcademy.com oppure tel. +39.035.515684


Conferenze

la quota comprende: ingresso alla conferenza, copia delle presentazioni dei relatori che le hanno rese disponibili, materiale informativo della giornata, networking lunch, coffee break, assistenza segreteria organizzativa, attestato di partecipazione. Per maggiori informazioni riguardanti l’iscrizione all’evento, potete contattare la segreteria organizzativa: events@LSAcademy.com oppure tel. +39(0)35.4123594

Webinars
la quota comprende: Ingresso al corso, documentazione didattica, assistenza segreteria organizzativa, attestato di partecipazione. Lo sconto early bird non si applica alla quota per Freelance – Accademia – Pubblica Amministrazione.  Per maggiori informazioni riguardanti l’iscrizione all’evento, potete contattare la segreteria organizzativa:
training@LSAcademy.com oppure tel. +39.035.515684


Condizioni comuni per Corsi e Conferenze

Termini di pagamento
L’importo dovrà essere versato ad EasyB S.r.l. all’atto dell’iscrizione tramite pagamento online (con carta di credito) o tramite bonifico bancario. In caso di bonifico bancario, l’importo dovrà essere versato a EasyB s.r.l. all’atto dell’iscrizione a:

EasyB S.r.l.
Via Roma, 20 – 24022 Alzano Lombardo (BG)
VAT: IT03633040161
Coordinate Bancarie:
BANCO BPM – Filiale di Carobbio Degli Angeli
SWIFT Code: BAPPIT21AY5
IBAN: IT81 F 05034 53960 000000003450

Solo la conferma dell’avvenuto pagamento consente la partecipazione all’evento. Seguirà fattura quietanzata. Iscrizioni ricevute in ritardo od oltre il numero massimo dei partecipanti o di figure professionali non in linea con il target dell’evento, potranno non essere accettate. Il pagamento della quota di iscrizione è dovuto contestualmente al ricevimento della scheda di registrazione. L’ammissione all’evento è confermata unicamente al ricevimento del pagamento. Potranno non essere accettate le iscrizioni ricevute in ritardo oppure oltre il numero massimo consentito dei partecipanti oppure di figure professionali non in linea con il target dell’evento.

Cancellazione
L’eventuale disdetta di partecipazione dovrà essere comunicata in forma scritta ad EasyB entro quattro settimane dall’evento; il rimborso è pari al 50% della quota. Dopo questo termine non verrà emesso nessun rimborso. Cambiamenti nei nominativi dei partecipanti sono gratuiti e da comunicare ad EasyB entro 7 giorni dalla data dell’evento. EasyB si riserva il diritto di posticipare o cancellare un evento, di cambiare la location di un evento o di modificare il panel dei relatori di un evento, di modificarne l’esecuzione da residenziale a webinar. EasyB non è responsabile per qualsiasi perdita o danno risultante da sostituzione, cambiamento, rinvio o cancellazione di un evento per cause al di fuori del proprio controllo, incluso a titolo esemplificativo e non esaustivo, cause di forza maggiore, disastri naturali, sabotaggi, infortuni, vertenze sindacali, atti di terrorismo, guerre, epidemie, pandemie, e/o blocchi dell’autorità ( c.d. factum principis).

Informativa Privacy
Ai sensi dell’art. 13 Reg. UE 27 Aprile 2016 n. 679, La informiamo che EasyB S.r.l., corrente in Alzano Lombardo (BG), via Roma 20 C.F e P.Iva 03633040161, in qualità di titolare del trattamento, tratterà i dati personali da lei volontariamente forniti solo previo consenso e nel rispetto dei principi dettati dal Regolamento Europeo in materia di protezione dei dati personali per l’invio di newsletter, per finalità di marketing (invio materiale pubblicitario, ricerche di mercato e comunicazione commerciale) e comunicazione dei medesimi dati a terzi (docenti e relatori, board scientifico, aziende che sponsorizzano la conferenza) anche per finalità di marketing. Potrà leggere l’informativa completa, compresi i diritti a lei spettanti e le modalità per l’esercizio degli stessi, cliccando su questo link.